Article Details
Retrieved on: 2021-05-24 06:11:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Monoclonal antibodies segment will also exhibit healthy growth at a CAGR of 7%, reaching revenues worth US$ 142.7 Mn by the end of 2024.
Article found on: www.mccourier.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here